About Us
What We Do
Our Team
Science
Lead Program
Mechanism of Action
Clinical Trials
Pipeline
Products
Our Products
Patients & Providers
Disease Information
Expanded Access Policy
Publications
IB1000 Series
News
Scientific Presentations
Contact
About Us
What We Do
Our Team
Science
Lead Program
Clinical Trials
Pipeline
Products
Our Products
Patients & Providers
Disease Information
Expanded Access Policy
Publications
IB1000 Series
News
Scientific Presentations
Contact
Subgroup Analysis by Phenotype in a Phase III, Randomized, Placebo-Controlled Crossover Trial with Levacetylleucine (IB1001) for Niemann-Pick Disease Type C
Privacy Policy
•
Cookies Policy
•
Consumer Product Safety Statement
•
State Compliance
•
Patents
•
©2026 IntraBio. All rights reserved.
